Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $10.8 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Morgan Stanley Upgrades Lineage Inc (LINE) to Overweight
• Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
• Barnes & Noble Education (BNED) Tops Q1 EPS by 12c